10-Q Filing

OPTION CARE HEALTH, INC. CIK: 1014739 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001014739-14-000013`
Period End Date	20140630
Filing Date	20140811
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	bios-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 96 Cash Flow Statement 105

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Allowance for Doubtful Accounts Receivable, Current	`AllowanceForDoubtfulAccountsReceivableCurrent`	$17.84M	USD	Point-in-time
Allowance for Doubtful Accounts Receivable, Current	`AllowanceForDoubtfulAccountsReceivableCurrent`	$26.34M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$62.10M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$81.64M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Receivables, less allowance for doubtful accounts of $26,340 and $17,836 as of June 30, 2014 and December 31, 2013, respectively	`ReceivablesNetCurrent`	$190.48M	USD	Point-in-time
Receivables, less allowance for doubtful accounts of $26,340 and $17,836 as of June 30, 2014 and December 31, 2013, respectively	`ReceivablesNetCurrent`	$172.19M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Inventory	`InventoryNet`	$34.48M	USD	Point-in-time
Inventory	`InventoryNet`	$34.34M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.11M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$12.29M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$15.32M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	70.71M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$236.96M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	71.18M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$238.79M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$41.18M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$39.86M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	68.59M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	68.13M	shares	Point-in-time
Treasury Stock, Shares	`TreasuryStockShares`	2.58M	shares	Point-in-time
Treasury Stock, Shares	`TreasuryStockShares`	2.58M	shares	Point-in-time
Goodwill	`Goodwill`	$571.34M	USD	Point-in-time
Goodwill	`Goodwill`	$572.93M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$13.50M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$16.82M	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$17.42M	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$17.18M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.32M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.73M	USD	Point-in-time
Non-current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$49.64M	USD	Point-in-time
Non-current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	-	USD	Point-in-time
Total assets	`Assets`	$883.82M	USD	Point-in-time
Total assets	`Assets`	$936.86M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$431.00K	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$60.26M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$69.75M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$63.58M	USD	Point-in-time
Claims payable	`SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves`	$4.02M	USD	Point-in-time
Claims payable	`SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves`	$2.55M	USD	Point-in-time
Amounts due to plan sponsors	`AmountsDueToPlanSponsors`	$5.64M	USD	Point-in-time
Amounts due to plan sponsors	`AmountsDueToPlanSponsors`	$4.83M	USD	Point-in-time
Accrued interest	`InterestPayableCurrentAndNoncurrent`	$6.94M	USD	Point-in-time
Accrued interest	`InterestPayableCurrentAndNoncurrent`	$2.17M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$34.35M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$38.80M	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.58M	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$125.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$174.31M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$375.32M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$418.31M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesGrossNoncurrent`	$16.33M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesGrossNoncurrent`	$8.95M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$17.54M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$8.58M	USD	Point-in-time
Other non-current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$6.15M	USD	Point-in-time
Other non-current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$582.27M	USD	Point-in-time
Total liabilities	`Liabilities`	$568.80M	USD	Point-in-time
Preferred stock, $.0001 par value; 5,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.0001 par value; 5,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.0001 par value; 125,000,000 shares authorized; 71,177,319 and 70,711,439 shares issued and 68,594,799 and 68,128,919 shares outstanding as of June 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Common stock, $.0001 par value; 125,000,000 shares authorized; 71,177,319 and 70,711,439 shares issued and 68,594,799 and 68,128,919 shares outstanding as of June 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Treasury stock, 2,582,520 shares at cost	`TreasuryStockValue`	$10.31M	USD	Point-in-time
Treasury stock, 2,582,520 shares at cost	`TreasuryStockValue`	$10.31M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$519.62M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$525.20M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-154.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-199.87M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$315.02M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$354.58M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$883.82M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$936.86M	USD	Point-in-time

Income Statement 96 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`HealthCareOrganizationOtherRevenue`	$150.56M	USD	1 Quarter
Product revenue	`HealthCareOrganizationOtherRevenue`	$441.18M	USD	2 Qtrs
Product revenue	`HealthCareOrganizationOtherRevenue`	$300.58M	USD	2 Qtrs
Product revenue	`HealthCareOrganizationOtherRevenue`	$225.28M	USD	1 Quarter
Service revenue	`HealthCareOrganizationPatientServiceRevenue`	$21.85M	USD	1 Quarter
Service revenue	`HealthCareOrganizationPatientServiceRevenue`	$45.24M	USD	2 Qtrs
Service revenue	`HealthCareOrganizationPatientServiceRevenue`	$52.76M	USD	2 Qtrs
Service revenue	`HealthCareOrganizationPatientServiceRevenue`	$21.76M	USD	1 Quarter
Total revenue	`HealthCareOrganizationRevenue`	$486.42M	USD	2 Qtrs
Total revenue	`HealthCareOrganizationRevenue`	$247.12M	USD	1 Quarter
Total revenue	`HealthCareOrganizationRevenue`	$353.34M	USD	2 Qtrs
Total revenue	`HealthCareOrganizationRevenue`	$172.32M	USD	1 Quarter
Cost of product revenue	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$313.40M	USD	2 Qtrs
Cost of product revenue	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$208.26M	USD	2 Qtrs
Cost of product revenue	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$102.72M	USD	1 Quarter
Cost of product revenue	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$161.66M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$11.82M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$20.11M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$31.32M	USD	2 Qtrs
Cost of service revenue	`CostOfServices`	$42.56M	USD	2 Qtrs
Total cost of revenue	`CostOfRevenue`	$181.77M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$355.96M	USD	2 Qtrs
Total cost of revenue	`CostOfRevenue`	$114.55M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$239.58M	USD	2 Qtrs
Gross profit	`GrossProfit`	$65.36M	USD	1 Quarter
Gross profit	`GrossProfit`	$57.77M	USD	1 Quarter
Gross profit	`GrossProfit`	$113.76M	USD	2 Qtrs
Gross profit	`GrossProfit`	$130.46M	USD	2 Qtrs
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$50.30M	USD	1 Quarter
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$57.24M	USD	1 Quarter
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$116.42M	USD	2 Qtrs
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$97.22M	USD	2 Qtrs
Change in fair value of contingent consideration	`GainLossonChangeinFairValueofContingentConsideration`	$6.86M	USD	2 Qtrs
Change in fair value of contingent consideration	`GainLossonChangeinFairValueofContingentConsideration`	$4.65M	USD	1 Quarter
Change in fair value of contingent consideration	`GainLossonChangeinFairValueofContingentConsideration`	-	USD	1 Quarter
Change in fair value of contingent consideration	`GainLossonChangeinFairValueofContingentConsideration`	-	USD	2 Qtrs
Bad debt expense	`ProvisionForDoubtfulAccounts`	$14.96M	USD	2 Qtrs
Bad debt expense	`ProvisionForDoubtfulAccounts`	$6.64M	USD	2 Qtrs
Bad debt expense	`ProvisionForDoubtfulAccounts`	$8.36M	USD	1 Quarter
Bad debt expense	`ProvisionForDoubtfulAccounts`	$3.46M	USD	1 Quarter
Acquisition and integration expenses	`AcquisitionAndIntegrationExpenses`	$3.51M	USD	1 Quarter
Acquisition and integration expenses	`AcquisitionAndIntegrationExpenses`	$8.13M	USD	2 Qtrs
Acquisition and integration expenses	`AcquisitionAndIntegrationExpenses`	$5.33M	USD	1 Quarter
Acquisition and integration expenses	`AcquisitionAndIntegrationExpenses`	$11.83M	USD	2 Qtrs
Restructuring and other expenses	`RestructuringCharges`	$2.68M	USD	2 Qtrs
Restructuring and other expenses	`RestructuringCharges`	$3.86M	USD	1 Quarter
Restructuring and other expenses	`RestructuringCharges`	$8.45M	USD	2 Qtrs
Restructuring and other expenses	`RestructuringCharges`	$1.44M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$3.79M	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.71M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$3.32M	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.62M	USD	1 Quarter
Loss from continuing operations	`OperatingIncomeLoss`	$-17.68M	USD	2 Qtrs
Loss from continuing operations	`OperatingIncomeLoss`	$-6.41M	USD	1 Quarter
Loss from continuing operations	`OperatingIncomeLoss`	$-4.70M	USD	2 Qtrs
Loss from continuing operations	`OperatingIncomeLoss`	$-2.64M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$12.99M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$19.63M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$9.13M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$6.51M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-15.55M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-37.31M	USD	2 Qtrs
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-9.15M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-17.69M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$146.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$3.06M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$6.55M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-29.00K	USD	2 Qtrs
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-18.61M	USD	1 Quarter
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-43.87M	USD	2 Qtrs
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-17.66M	USD	2 Qtrs
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-9.30M	USD	1 Quarter
Income (loss) from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$651.00K	USD	2 Qtrs
Income (loss) from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.26M	USD	2 Qtrs
Income (loss) from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.21M	USD	1 Quarter
Income (loss) from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$416.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.88M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-17.01M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-45.13M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-19.82M	USD	1 Quarter
Loss from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.27	USD	1 Quarter
Loss from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.14	USD	1 Quarter
Loss from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.64	USD	2 Qtrs
Loss from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.29	USD	2 Qtrs
Income (loss) from discontinued operations, basic and diluted	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.01	USD	2 Qtrs
Income (loss) from discontinued operations, basic and diluted	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Income (loss) from discontinued operations, basic and diluted	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.02	USD	2 Qtrs
Income (loss) from discontinued operations, basic and diluted	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.02	USD	1 Quarter
Loss per common share, basic and diluted	`EarningsPerShareBasic`	$-0.14	USD	1 Quarter
Loss per common share, basic and diluted	`EarningsPerShareBasic`	$-0.29	USD	1 Quarter
Loss per common share, basic and diluted	`EarningsPerShareBasic`	$-0.28	USD	2 Qtrs
Loss per common share, basic and diluted	`EarningsPerShareBasic`	$-0.66	USD	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	65.03M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	61.06M	shares	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.35M	shares	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.47M	shares	1 Quarter

Cash Flow Statement 105 line items

Line Item	Tag	Value	Unit	Period
Net (loss)	`NetIncomeLoss`	$-8.88M	USD	1 Quarter
Net (loss)	`NetIncomeLoss`	$-17.01M	USD	2 Qtrs
Net (loss)	`NetIncomeLoss`	$-45.13M	USD	2 Qtrs
Net (loss)	`NetIncomeLoss`	$-19.82M	USD	1 Quarter
Less: income (loss) from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$651.00K	USD	2 Qtrs
Less: income (loss) from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.26M	USD	2 Qtrs
Less: income (loss) from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.21M	USD	1 Quarter
Less: income (loss) from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$416.00K	USD	1 Quarter
(Loss) from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-18.61M	USD	1 Quarter
(Loss) from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-43.87M	USD	2 Qtrs
(Loss) from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-17.66M	USD	2 Qtrs
(Loss) from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-9.30M	USD	1 Quarter
Depreciation	`Depreciation`	$3.96M	USD	1 Quarter
Depreciation	`Depreciation`	$4.95M	USD	2 Qtrs
Depreciation	`Depreciation`	$2.53M	USD	1 Quarter
Depreciation	`Depreciation`	$7.79M	USD	2 Qtrs
Amortization of intangibles	`AdjustmentForAmortization`	$3.79M	USD	2 Qtrs
Amortization of intangibles	`AdjustmentForAmortization`	$3.32M	USD	2 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$2.75M	USD	2 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$722.00K	USD	2 Qtrs
Change in fair value of contingent consideration	`IncreaseDecreaseinFairValueofContingentConsideration`	-	USD	2 Qtrs
Change in fair value of contingent consideration	`IncreaseDecreaseinFairValueofContingentConsideration`	$6.86M	USD	2 Qtrs
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-6.36M	USD	2 Qtrs
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-1.02M	USD	2 Qtrs
Compensation under stock-based compensation plans	`ShareBasedCompensation`	$2.00M	USD	1 Quarter
Compensation under stock-based compensation plans	`ShareBasedCompensation`	$3.86M	USD	1 Quarter
Compensation under stock-based compensation plans	`ShareBasedCompensation`	$4.88M	USD	2 Qtrs
Compensation under stock-based compensation plans	`ShareBasedCompensation`	$5.83M	USD	2 Qtrs
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$16.00K	USD	2 Qtrs
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Equity in net loss of unconsolidated affiliate	`IncomeLossFromEquityMethodInvestments`	-	USD	2 Qtrs
Equity in net loss of unconsolidated affiliate	`IncomeLossFromEquityMethodInvestments`	$-661.00K	USD	2 Qtrs
Receivables, net of bad debt expense	`IncreaseDecreaseInReceivables`	$15.89M	USD	2 Qtrs
Receivables, net of bad debt expense	`IncreaseDecreaseInReceivables`	$19.02M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$58.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-10.10M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-3.75M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.28M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$6.32M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$6.11M	USD	2 Qtrs
Claims payable	`IncreaseDecreaseInFuturePolicyBenefitReserves`	$-3.56M	USD	2 Qtrs
Claims payable	`IncreaseDecreaseInFuturePolicyBenefitReserves`	$1.48M	USD	2 Qtrs
Amounts due to plan sponsors	`IncreaseDecreaseinAmountsduetoplansponsor`	$816.00K	USD	2 Qtrs
Amounts due to plan sponsors	`IncreaseDecreaseinAmountsduetoplansponsor`	$-7.84M	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$4.76M	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$-38.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.12M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-12.47M	USD	2 Qtrs
Net cash (used in) operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-26.67M	USD	2 Qtrs
Net cash (used in) operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-22.80M	USD	2 Qtrs
Net cash provided by (used in) by operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-4.30M	USD	2 Qtrs
Net cash provided by (used in) by operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$745.00K	USD	2 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.06M	USD	2 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-30.98M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsForProceedsFromProductiveAssets`	$6.92M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsForProceedsFromProductiveAssets`	$10.98M	USD	2 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$234.00K	USD	2 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Cash consideration paid for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$454.00K	USD	2 Qtrs
Cash consideration paid for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$72.92M	USD	2 Qtrs
Net cash proceeds from sale of unconsolidated affiliate	`ProceedsFromSaleOfEquityMethodInvestments`	$8.51M	USD	2 Qtrs
Net cash proceeds from sale of unconsolidated affiliate	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	2 Qtrs
Cash advances to unconsolidated affiliate	`PaymentsForAdvanceToAffiliate`	$2.35M	USD	2 Qtrs
Cash advances to unconsolidated affiliate	`PaymentsForAdvanceToAffiliate`	-	USD	2 Qtrs
Net cash (used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-7.38M	USD	2 Qtrs
Net cash (used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-77.50M	USD	2 Qtrs
Net cash provided by (used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$57.69M	USD	2 Qtrs
Net cash provided by (used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-37.00K	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-77.54M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$50.31M	USD	2 Qtrs
Proceeds from public stock offering	`ProceedsFromIssuanceOfCommonStock`	$118.57M	USD	2 Qtrs
Proceeds from public stock offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from new senior notes due 2021, net of lender fees and other expenses	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$193.87M	USD	2 Qtrs
Proceeds from new senior notes due 2021, net of lender fees and other expenses	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	2 Qtrs
Deferred and other financing costs	`PaymentsOfFinancingCosts`	$1.16M	USD	2 Qtrs
Deferred and other financing costs	`PaymentsOfFinancingCosts`	-	USD	2 Qtrs
Borrowings on line of credit	`ProceedsFromLinesOfCredit`	$85.40M	USD	2 Qtrs
Borrowings on line of credit	`ProceedsFromLinesOfCredit`	$351.86M	USD	2 Qtrs
Repayments on line of credit	`RepaymentsOfLinesOfCredit`	$21.00M	USD	Point-in-time
Repayments on line of credit	`RepaymentsOfLinesOfCredit`	$351.86M	USD	2 Qtrs
Repayments on line of credit	`RepaymentsOfLinesOfCredit`	$125.40M	USD	2 Qtrs
Principal payments on long-term debt	`ProceedsFromRepaymentsOfSecuredDebt`	$-172.24M	USD	2 Qtrs
Principal payments on long-term debt	`ProceedsFromRepaymentsOfSecuredDebt`	-	USD	2 Qtrs
Repayments of capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$151.00K	USD	2 Qtrs
Repayments of capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$884.00K	USD	2 Qtrs
Net proceeds from exercise of common stock purchase warrants	`ProceedsFromWarrantExercises`	$399.00K	USD	2 Qtrs
Net proceeds from exercise of common stock purchase warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Net proceeds from exercise of employee stock compensation plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$905.00K	USD	2 Qtrs
Net proceeds from exercise of employee stock compensation plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$1.05M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$119.14M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-18.79M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$546.00K	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$19.54M	USD	2 Qtrs
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.55M	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$62.10M	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$81.64M	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.55M	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$62.10M	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$81.64M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$12.33M	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$12.23M	USD	2 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaidNet`	$349.00K	USD	2 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaidNet`	$235.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.